by Suzanne D. Vernon, PhD | Sep 3, 2021 | BHC News, Home, Long COVID, ME/CFS, Newsletters
In 2018 the Food and Drug Administration approved a physician-sponsored Investigational New Drug (IND) Application, to investigate the safety, tolerability and efficacy of CT38 in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Dr....
by Suzanne D. Vernon, PhD | Jul 9, 2021 | BHC News, Research News, Uncategorized
BHC: A Unique Clinical Research Center Of all of the places I’ve worked, BHC is the one with the greatest promise to improve the lives of those impacted by ME/CFS, FM and post-viral illnesses. Why? Because of our unique model of clinical care, research, and education....
by Suzanne D. Vernon, PhD | Nov 25, 2020 | Fibromyalgia, Home, ME/CFS, Orthostatic Intolerance, Research News, Uncategorized
It’s Research Week at Bateman Horne Center! This means that as part of our Mission Possible giving campaign we fill you in on why research is so important to our organization and how we are using it to improve the lives of those with ME/CFS, fibromyalgia,...
by Suzanne D. Vernon, PhD | Nov 14, 2020 | BHC News, Home, Orthostatic Intolerance, Research News
Turning a Self-Report Questionnaire into a Wearable Device Well-defined and reliable tools are needed for objective diagnosis and to measure clinically relevant outcomes of treatment for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The 2015 Institute...
